Cover Image
市场调查报告书

心脏辅助装置:医疗设备的开发平台评估

Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品编码 351422
出版日期 内容信息 英文 286 Pages
订单完成后即时交付
价格
Back to Top
心脏辅助装置:医疗设备的开发平台评估 Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年06月01日 内容信息: 英文 286 Pages
简介

本报告提供心脏辅助装置的开发中产品相关调查,提供您各开发阶段趋势和产品的主要开发企业,现在进行中的临床实验,产业的最近事件等信息。

第1章 目录

第2章 简介

  • 心脏辅助装置概要

第3章 开发中的产品

  • 开发中产品:各开发阶段
  • 开发中产品:各市场区隔
  • 开发中产品:地区 (国家) 别
  • 开发中产品:法规途径别
  • 开发中产品:核准时期别 (估计)
  • 进行中临床实验

第4章 心脏辅助装置 - 正在开发的开发中产品:各企业

  • 开发企业 - 开发中产品:各开发阶段
  • 开发中产品:各开发阶段

第5章 心脏辅助装置的开发企业与产品概要

  • Abiomed, Inc.
  • Acorn Cardiovascular, Inc.
  • Arrow International Cr, A.S.
  • Biophan Technologies, Inc.
  • BioQ Devices Pty Ltd
  • BioVentrix, Inc.
  • BiVacor Pty Ltd
  • Braile Biomedica Ltda.
  • Calon Cardio-Technology Ltd
  • Cardiac Power Inc.
  • CardiacAssist, Inc.
  • Cardiak Ltd.
  • CARDIAnove
  • Cardio Vox, Inc.
  • CardioBridge GmbH
  • CardioKinetix, Inc.
  • CardioPlus, Inc.
  • Carmat SAS
  • Charite - Universitatsmedizin Berlin
  • Cleveland Heart, Inc.
  • CorasMedical
  • CorAssist Cardiovascular Ltd.
  • CorInnova, Inc.
  • CorWave
  • Drexel University
  • DUALIS MedTech GmbH
  • Ension, Inc.
  • Evaheart, Inc.
  • Everheart Systems, LLC
  • Foster-Miller, Inc. (Inactive)
  • Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
  • Gold Medical Technologies, Inc.
  • Harvard University
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • LaunchPoint Technologies, Inc.
  • Leviticus Cardio Ltd.
  • Levram Medical Systems Ltd
  • Lonestar Heart, Inc.
  • Mayo Clinic.
  • MicroMed Cardiovascular, Inc.
  • Microstim GmbH
  • MyoCardioCare, Inc.
  • MyoPowers Medical Technologies SA
  • NeoCardial Technologies, LLC
  • New Heart
  • Nipro Corporation
  • NuVascular Technologies Inc
  • Orqis Medical Corporation
  • Penn State Milton S. Hershey Medical Center
  • Perfusion Solutions
  • PlugMed Heart SAS
  • Procyrion
  • Purdue University
  • QRS Diagnostic, LLC
  • ReliantHeart, Inc.
  • Saint Louis University
  • St. Jude Medical, Inc.
  • Sunshine Heart Company, Pty. Ltd.
  • SynCardia Systems, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development
  • The University of Tokyo
  • U.S. Stem Cell, Inc.
  • University of Minnesota
  • University of Zurich
  • Vadovations, Inc.
  • Vienna University of Technology
  • Windmill Cardiovascular Systems, Inc.

第6章 心脏辅助装置 - 最近的事件

第7章 附录

本网页内容可能与最新版本有所差异。详细情况请与我们联系。

目录
Product Code: GDME0558EPD

GlobalData's Medical Devices sector report, "Cardiac Assist Devices - Medical Devices Pipeline Assessment, 2018" provides an overview of Cardiac Assist Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Cardiac Assist Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Cardiac Assist Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Assist Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Assist Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 7
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Cardiac Assist Devices Overview 15

3 Products under Development 16

  • 3.1 Cardiac Assist Devices - Pipeline Products by Stage of Development 16
  • 3.2 Cardiac Assist Devices - Pipeline Products by Segment 17
  • 3.3 Cardiac Assist Devices - Pipeline Products by Territory 18
  • 3.4 Cardiac Assist Devices - Pipeline Products by Regulatory Path 19
  • 3.5 Cardiac Assist Devices - Pipeline Products by Estimated Approval Date 20
  • 3.6 Cardiac Assist Devices - Ongoing Clinical Trials 21

4 Cardiac Assist Devices - Pipeline Products under Development by Companies 22

  • 4.1 Cardiac Assist Devices Companies - Pipeline Products by Stage of Development 22
  • 4.2 Cardiac Assist Devices - Pipeline Products by Stage of Development 26

5 Cardiac Assist Devices Companies and Product Overview 30

  • 5.1 Abiomed Inc Company Overview 30
  • 5.2 Acorn Cardiovascular, Inc. (Inactive) Company Overview 40
  • 5.3 Berlin Heart GmbH Company Overview 41
  • 5.4 BioQ Devices Pty Ltd Company Overview 42
  • 5.5 BioSurfaces, Inc. Company Overview 43
  • 5.6 BioVentrix Inc Company Overview 44
  • 5.7 BiVacor Pty Ltd Company Overview 47
  • 5.8 Braile Biomedica Ltda Company Overview 48
  • 5.9 Calon Cardio-Technology Ltd Company Overview 49
  • 5.10 CardiacAssist Inc Company Overview 51
  • 5.11 Cardiak Ltd. Company Overview 52
  • 5.12 CARDIAnove Company Overview 53
  • 5.13 CardioBridge GmbH Company Overview 54
  • 5.14 Carmat SAS Company Overview 56
  • 5.15 Carnegie Mellon University Company Overview 59
  • 5.16 Cleveland Clinic Hospital Company Overview 60
  • 5.17 Cleveland Heart Inc Company Overview 61
  • 5.18 CorasMedical Company Overview 63
  • 5.19 CorAssist Cardiovascular Ltd Company Overview 64
  • 5.20 Corinnova Inc Company Overview 68
  • 5.21 CorWave Company Overview 73
  • 5.22 DHS Medical Company Overview 75
  • 5.23 Drexel University Company Overview 76
  • 5.24 DUALIS MedTech GmbH Company Overview 77
  • 5.25 Duke University Company Overview 78
  • 5.26 Ension, Inc. Company Overview 79
  • 5.27 Evaheart Inc Company Overview 81
  • 5.28 Everheart Systems, LLC Company Overview 82
  • 5.29 FineHeart Company Overview 83
  • 5.30 Foster-Miller Inc (Inactive) Company Overview 84
  • 5.31 Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Company Overview 85
  • 5.32 Harvard University Company Overview 86
  • 5.33 HeartWare International Inc Company Overview 88
  • 5.34 Indian Institute of Technology Kharagpur Company Overview 99
  • 5.35 Indiana University Company Overview 100
  • 5.36 International Biophysics Corp Company Overview 101
  • 5.37 Jarvik Heart Inc Company Overview 102
  • 5.38 LaunchPoint Technologies, Inc. Company Overview 107
  • 5.39 Leviticus Cardio Ltd Company Overview 109
  • 5.40 Levram Medical Systems Ltd Company Overview 110
  • 5.41 Medtronic plc Company Overview 111
  • 5.42 Michigan Critical Care Consultants, Inc. Company Overview 112
  • 5.43 Microstim GmbH Company Overview 113
  • 5.44 MyoCardioCare, Inc. Company Overview 114
  • 5.45 Myotech, LLC (Inactive) Company Overview 116
  • 5.46 NeoCardial Technologies, LLC Company Overview 117
  • 5.47 Nipro Corp Company Overview 118
  • 5.48 Novapump GmbH Company Overview 119
  • 5.49 NuPulseCV Company Overview 121
  • 5.50 OregonHeart Inc (Inactive) Company Overview 122
  • 5.51 Orqis Medical Corp (Inactive) Company Overview 123
  • 5.52 Penn State Milton S Hershey Medical Center Company Overview 124
  • 5.53 Pennsylvania State University Company Overview 125
  • 5.54 Perfusion Solution Inc Company Overview 126
  • 5.55 PlugMed Heart SAS Company Overview 128
  • 5.56 Procyrion Company Overview 129
  • 5.57 Purdue University Company Overview 130
  • 5.58 ReliantHeart, Inc. Company Overview 131
  • 5.59 Rutgers The State University of New Jersey Company Overview 136
  • 5.60 Saint Louis University Company Overview 137
  • 5.61 Scandinavian Real Heart AB Company Overview 139
  • 5.62 Second Heart Assist Inc Company Overview 140
  • 5.63 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 142
  • 5.64 St. Jude Medical LLC Company Overview 144
  • 5.65 Sunshine Heart Company, Pty. Ltd. Company Overview 146
  • 5.66 Syncardia Systems LLC Company Overview 147
  • 5.67 TEDA International Cardiovascular Hospital Company Overview 155
  • 5.68 Teleflex Inc Company Overview 156
  • 5.69 Terumo Corp Company Overview 158
  • 5.70 The Artificial Heart Laboratory of Foundation for Cardiac Surgery Development Company Overview 159
  • 5.71 Thoratec Corp Company Overview 160
  • 5.72 Tokyo Medical and Dental University Company Overview 168
  • 5.73 U.S. Stem Cell Inc Company Overview 169
  • 5.74 University of California Irvine Company Overview 170
  • 5.75 University of Louisville Company Overview 171
  • 5.76 University of Michigan Company Overview 172
  • 5.77 University of Tokyo Company Overview 173
  • 5.78 University of Vienna Company Overview 174
  • 5.79 Vadovations, Inc. Company Overview 175
  • 5.80 Vienna University of Technology Company Overview 176
  • 5.81 Windmill Cardiovascular Systems, Inc. Company Overview 177
  • 5.82 Yale University Company Overview 178

6 Cardiac Assist Devices- Recent Developments 180

  • 6.1 May 23, 2018: Acarix appoints senior cardiovascular medtech marketing expert as member of the Board of Directors 180
  • 6.2 May 23, 2018: Acarix recruits Per Persson as Chief Commercial Officer 180
  • 6.3 May 22, 2018: Abbott Recalls the HeartMate 3 Left Ventricular Assist System Due to Potential Malfunction that may Lead to Graft Occlusion 180
  • 6.4 May 18, 2018: Adherium's Technology Used for Large Scale Electronic Data Capture in Landmark Mild-Asthma Trials 181
  • 6.5 May 18, 2018: Getinge to showcase innovative products and present ExpoEd sessions at upcoming National Teaching Institute & Critical Care Exposition 2018 182
  • 6.6 May 17, 2018: Artificial heart technology gets federal funding 183
  • 6.7 May 15, 2018: Getinge announces its commitment to EuroPCR 183
  • 6.8 May 15, 2018: Micron Solutions Reports 2018 First Quarter Results 184
  • 6.9 May 14, 2018: Real Heart: Continued progress in the second preclinical trial 184
  • 6.10 May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration 185
  • 6.11 May 11, 2018: Terumo Appoints its U.S.-based Subsidiary's Associate as the Fifth Terumo Fellow 186
  • 6.12 May 11, 2018: Teleflex: Reaffirms 2018 Guidance and Provides 3-Year Financial Goals and Objectives 186
  • 6.13 May 09, 2018: U.S. Stem Cell Reports First Quarter Results 187
  • 6.14 May 04, 2018: Abbott Implements Corrective Action for HeartMate 3 Heart Pump 188
  • 6.15 May 03, 2018: Abiomed Announces Q4 FY 2018 Revenue of $174 Million, Up 40%, and Total Year Revenue of $594 Million, Up 33%, Over Prior Year 188
  • 6.16 May 03, 2018: Teleflex Reports First Quarter 2018 Results 189
  • 6.17 Apr 30, 2018: Procyrion Appoints Clinical Operations Pro Tara Burt As Associate Director Of Clinical Affairs 192
  • 6.18 Apr 26, 2018: Getinge publishes Interim Report for January-March 2018 192
  • 6.19 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 193
  • 6.20 Apr 24, 2018: Edwards Life sciences Announces First Quarter 2018 Financial Results 193
  • 6.21 Apr 16, 2018: USRM Reports 2017 Financial Results 195
  • 6.22 Apr 10, 2018: Leviticus Cardio Confirms the Successful Completion of a Long-term Chronic Animal Study 196
  • 6.23 Apr 09, 2018: Medtronic to Unveil Additional Clinical Data on HVAD System at ISHLT 2018 197
  • 6.24 Apr 05, 2018: CARMAT: Continuing Progress in Line with the Objective of Obtaining CE Marking in 2019 198
  • 6.25 Apr 04, 2018: Abiomed Announces European Approval (CE Marking) for Impella 5.5 and First Patient Treated at University Heart Center Hamburg 199
  • 6.26 Apr 02, 2018: Abiomed Receives FDA Approval for Impella CP with SmartAssist and Optical Sensor 200
  • 6.27 Mar 30, 2018: Abiomed to Appoint New Chief Financial Officer Todd A. Trapp 202
  • 6.28 Mar 26, 2018: Micron Solutions Reports 2017 Fourth Quarter and Year End Results 202
  • 6.29 Mar 21, 2018: Procyrion Names Elisabeth Neely Senior Vice President Of Clinical And Regulatory Affairs, Formerly With Abbott 203
  • 6.30 Mar 14, 2018: Baylor College of Medicine approved for $489,000 in funding for LVAD treatment decision support 204
  • 6.31 Mar 13, 2018: UR Medicine Leads U.S. in Minimally Invasive Surgery for Newest LVAD Heart Pump 205
  • 6.32 Mar 11, 2018: New Long-term Data Show Improved Survival and Lower Rates of Stroke and Pump Thrombosis for Abbott's Heartmate 3 Heart Pump 207
  • 6.33 Mar 05, 2018: Abiomed Showcases Impella Technology that Enables Heart Recovery at ACC with 25 Presentations 208
  • 6.34 Mar 01, 2018: Palmetto Health is first facility in state to implant HeartMate 3 LVAD outside of research trials 209
  • 6.35 Feb 28, 2018: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2017; Merit Meets Range of 2017 Guidance; Gives 2018 Guidance 210
  • 6.36 Feb 27, 2018: Scandinavian Real Heart Selects AdaCore Embedded Software Development Platform for Revolutionary Artificial Heart 211
  • 6.37 Feb 26, 2018: Successful Outcomes Seen in First-in-Human Trial of NuPulseCV's Intravascular Ventricular Assist System (iVAS) 212
  • 6.38 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 213
  • 6.39 Feb 20, 2018: CARMAT Advances the Internationalization of the PIVOTAL Study and Obtains the Approval to Perform Implants in Denmark 215
  • 6.40 Feb 14, 2018: Abiomed Receives Approval for Expanded FDA Indication for High Risk Percutaneous Coronary Intervention (PCI) Procedures 215
  • 6.41 Feb 13, 2018: Abiomed Receives Approval for Expanded FDA Indication for Cardiomyopathy with Cardiogenic Shock 217
  • 6.42 Feb 13, 2018: Abiomed Announces Peripartum and Postpartum Cardiomyopathy Approval and Women's Initiative for Heart Recovery 218
  • 6.43 Feb 13, 2018: Carmat: 2017 Annual Results 219
  • 6.44 Feb 08, 2018: Terumo Revises the Full-Year Results Forecast for FY 2017 221
  • 6.45 Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy 221
  • 6.46 Feb 01, 2018: Abiomed Announces Q3 FY 2018 Record Revenue of $154 Million, Up 34% Over Prior Year 222
  • 6.47 Feb 01, 2018: Edwards Life sciences Reports Fourth Quarter Results 223
  • 6.48 Jan 29, 2018: Getinge Reported Net Sales Of SEK22,495 M In 2017 224
  • 6.49 Jan 25, 2018: Terumo Announces Change of Directors and Executive Officers 225
  • 6.50 Jan 17, 2018: International Biophysics obtains FDA 510k clearance for the FloPump 32 centrifugal heart pump 227
  • 6.51 Jan 10, 2018: Ventripoint Appoints Head of Sales for North America 227
  • 6.52 Jan 08, 2018: Abiomed Announces Preliminary Q3 FY 2018 Revenue of $154M, Up 34% Over Prior Year 228
  • 6.53 Jan 04, 2018: Apollo Hospitals, Hyderguda successfully implanted the LVAD Heart Mate 3 to give a new lease of life for a 70-year-old heart failure patient. 228
  • 6.54 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 229

7 Appendix 281

  • 7.1 Methodology 281
  • 7.2 About GlobalData 284
  • 7.3 Contact Us 284
  • 7.4 Disclaimer 284

List of Tables

1.1 List of Tables

  • Table 1: Cardiac Assist Devices - Pipeline Products by Stage of Development 18
  • Table 2: Cardiac Assist Devices - Pipeline Products by Segment 19
  • Table 3: Cardiac Assist Devices - Pipeline Products by Territory 20
  • Table 4: Cardiac Assist Devices - Pipeline Products by Regulatory Path 21
  • Table 5: Cardiac Assist Devices - Pipeline Products by Estimated Approval Date 22
  • Table 6: Cardiac Assist Devices - Ongoing Clinical Trials 23
  • Table 7: Cardiac Assist Devices Companies - Pipeline Products by Stage of Development 24
  • Table 8: Cardiac Assist Devices - Pipeline Products by Stage of Development 28
  • Table 9: Abiomed Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 10: AbioCor II - Product Status 32
  • Table 11: AbioCor II - Product Description 33
  • Table 12: Impella BTR - Product Status 33
  • Table 13: Impella BTR - Product Description 33
  • Table 14: Impella CP (Cardiac Power) - Product Status 34
  • Table 15: Impella CP (Cardiac Power) - Product Description 34
  • Table 16: Impella ECP - Product Status 34
  • Table 17: Impella ECP - Product Description 35
  • Table 18: Impella RP - Product Status 35
  • Table 19: Impella RP - Product Description 35
  • Table 20: Next Generation Impella CP - STEMI - Product Status 36
  • Table 21: Next Generation Impella CP - STEMI - Product Description 36
  • Table 22: Symphony Heart Pump - Product Status 36
  • Table 23: Symphony Heart Pump - Product Description 37
  • Table 24: Abiomed Inc - Ongoing Clinical Trials Overview 38
  • Table 25: Impella RP - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry 39
  • Table 26: Impella CP (Cardiac Power) - A global Initiative in Percutaneous Circulatory Support from the cVAD Steering Committee on Behalf of All cVAD Investigators: Global cVAD Registry 40
  • Table 27: Impella CP (Cardiac Power) - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial 40
  • Table 28: Impella CP (Cardiac Power) - Pulsecath mechanical Support Evaluation (PULSE) - Trial 40
  • Table 29: Next Generation Impella CP - STEMI - Door to Unloading with IMPELLA CP System in Acute Myocardial Infarction to Reduce Infarct Size (DTU): A Prospective Feasibility Study 41
  • Table 30: Acorn Cardiovascular, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 31: CorCap Cardiac Support Device - Product Status 42
  • Table 32: CorCap Cardiac Support Device - Product Description 42
  • Table 33: Berlin Heart GmbH Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 34: Low - Stress Rotary Blood Pump - Product Status 43
  • Table 35: Low - Stress Rotary Blood Pump - Product Description 43
  • Table 36: BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 37: BioQ IntraAortic Counterpulsation Prosthesis - Product Status 44
  • Table 38: BioQ IntraAortic Counterpulsation Prosthesis - Product Description 44
  • Table 39: BioSurfaces, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 40: Artificial Heart Assist Device Conduit - Product Status 45
  • Table 41: Artificial Heart Assist Device Conduit - Product Description 45
  • Table 42: BioVentrix Inc Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 43: PliCath HF - Product Status 46
  • Table 44: PliCath HF - Product Description 46
  • Table 45: BioVentrix Inc - Ongoing Clinical Trials Overview 47
  • Table 46: PliCath HF - Phase II Study of the BioVentrix PliCath HF System for the Treatment of Ischemic Cardiomyopathy 48
  • Table 47: BiVacor Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 48: BiVACOR Device - Product Status 49
  • Table 49: BiVACOR Device - Product Description 49
  • Table 50: Braile Biomedica Ltda Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 51: Blood Pump - Product Status 50
  • Table 52: Blood Pump - Product Description 50
  • Table 53: Calon Cardio-Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 54: Calon MiniVAD - Product Status 51
  • Table 55: Calon MiniVAD - Product Description 51
  • Table 56: CathVAD - Product Status 52
  • Table 57: CathVAD - Product Description 52
  • Table 58: MicroVAD - Product Status 52
  • Table 59: MicroVAD - Product Description 52
  • Table 60: CardiacAssist Inc Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 61: Pediatric pVAD - Product Status 53
  • Table 62: Pediatric pVAD - Product Description 53
  • Table 63: Cardiak Ltd. Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 64: Akpulsor - Product Status 54
  • Table 65: Akpulsor - Product Description 54
  • Table 66: CARDIAnove Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 67: CARDIAnove Pump - Product Status 55
  • Table 68: CARDIAnove Pump - Product Description 55
  • Table 69: CardioBridge GmbH Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 70: 10F RCP System - Product Status 56
  • Table 71: 10F RCP System - Product Description 56
  • Table 72: 14F RCP System - Product Status 57
  • Table 73: 14F RCP System - Product Description 57
  • Table 74: Carmat SAS Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 75: Artificial Heart - Product Status 58
  • Table 76: Artificial Heart - Product Description 58
  • Table 77: Carmat SAS - Ongoing Clinical Trials Overview 59
  • Table 78: Artificial Heart - Clinical Evaluation of the Carmat Total Artificial Heart for Patients with Advanced Heart Failure 60
  • Table 79: Carnegie Mellon University Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 80: tVAD - Heart Failure - Product Status 61
  • Table 81: tVAD - Heart Failure - Product Description 61
  • Table 82: Cleveland Clinic Hospital Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 83: PediPump - Product Status 62
  • Table 84: PediPump - Product Description 62
  • Table 85: Cleveland Heart Inc Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 86: SmartHeart LVAD - Product Status 63
  • Table 87: SmartHeart LVAD - Product Description 63
  • Table 88: SmartHeart TAH - Product Status 64
  • Table 89: SmartHeart TAH - Product Description 64
  • Table 90: CorasMedical Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 91: CORAS Hotor - Product Status 65
  • Table 92: CORAS Hotor - Product Description 65
  • Table 93: CorAssist Cardiovascular Ltd Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 94: CORolla - Product Status 66
  • Table 95: CORolla - Product Description 66
  • Table 96: ImCardia - Product Status 67
  • Table 97: ImCardia - Product Description 67
  • Table 98: CorAssist Cardiovascular Ltd - Ongoing Clinical Trials Overview 68
  • Table 99: CORolla - CORolla TAA for Heart Failure and Preserved Ejection Fraction and Diastolic Dysfunction 69
  • Table 100: CORolla - CORolla TAA for Heart Failure with Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD) Safety and Feasibility 69
  • Table 101: Corinnova Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 102: CardiacSTAR - Bridge To Decision - Product Status 70
  • Table 103: CardiacSTAR - Bridge To Decision - Product Description 70
  • Table 104: CardiacSTAR - Bridge To Recovery - Product Status 71
  • Table 105: CardiacSTAR - Bridge To Recovery - Product Description 71
  • Table 106: CardiacSTAR - Bridge To Transplant - Product Status 71
  • Table 107: CardiacSTAR - Bridge To Transplant - Product Description 72
  • Table 108: CardiacSTAR - Destination Therapy - Product Status 72
  • Table 109: CardiacSTAR - Destination Therapy - Product Description 72
  • Table 110: CardiacSTAR - Heart Rehabilitation - Product Status 73
  • Table 111: CardiacSTAR - Heart Rehabilitation - Product Description 73
  • Table 112: EpicHeart - Soft Robotic Heart Device - Product Status 73
  • Table 113: EpicHeart - Soft Robotic Heart Device - Product Description 74
  • Table 114: CorWave Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 115: CorWave Neptune - Product Status 75
  • Table 116: CorWave Neptune - Product Description 75
  • Table 117: CorWave Nemo - Product Status 76
  • Table 118: CorWave Nemo - Product Description 76
  • Table 119: DHS Medical Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 120: Implantable Device - Diastolic Heart Failure - Product Status 77
  • Table 121: Implantable Device - Diastolic Heart Failure - Product Description 77
  • Table 122: Drexel University Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 123: Intravascular Blood Pump - Product Status 78
  • Table 124: Intravascular Blood Pump - Product Description 78
  • Table 125: DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 79
  • Table 126: CAREFLOW Pump - Product Status 79
  • Table 127: CAREFLOW Pump - Product Description 79
  • Table 128: Duke University Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 129: Para-Aortic Blood Pump - Product Status 80
  • Table 130: Para-Aortic Blood Pump - Product Description 80
  • Table 131: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 132: CardioFlowPQ - Product Status 81
  • Table 133: CardioFlowPQ - Product Description 81
  • Table 134: pCAS - Product Status 82
  • Table 135: pCAS - Product Description 82
  • Table 136: Evaheart Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 137: EVAHEART Left Ventricular Assist System - Product Status 83
  • Table 138: EVAHEART Left Ventricular Assist System - Product Description 83
  • Table 139: Everheart Systems, LLC Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 140: Fully Implantable Left Ventricular Assist Device - Product Status 84
  • Table 141: Fully Implantable Left Ventricular Assist Device - Product Description 84
  • Table 142: FineHeart Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 143: ICOMS - Product Status 85
  • Table 144: ICOMS - Product Description 85
  • Table 145: Foster-Miller Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 146: MagScrew Total Artificial Heart - Product Status 86
  • Table 147: MagScrew Total Artificial Heart - Product Description 86
  • Table 148: Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 149: Ventricular Assist Device - Product Status 87
  • Table 150: Ventricular Assist Device - Product Description 87
  • Table 151: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 152: Implantable Direct Cardiac Compression Device - Product Status 88
  • Table 153: Implantable Direct Cardiac Compression Device - Product Description 88
  • Table 154: Soft Robotic Sleeve - Product Status 89
  • Table 155: Soft Robotic Sleeve - Product Description 89
  • Table 156: HeartWare International Inc Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 157: BiVAD - Product Status 90

List of Figures

1.2 List of Figures

  • Figure 1: Cardiac Assist Devices - Pipeline Products by Stage of Development 18
  • Figure 2: Cardiac Assist Devices - Pipeline Products by Segment 19
  • Figure 3: Cardiac Assist Devices - Pipeline Products by Territory 20
  • Figure 4: Cardiac Assist Devices - Pipeline Products by Regulatory Path 21
  • Figure 5: Cardiac Assist Devices - Pipeline Products by Estimated Approval Date 22
  • Figure 6: Cardiac Assist Devices - Ongoing Clinical Trials 23
Back to Top